| Title |
Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer
|
|---|---|
| Published in |
Clinical Cancer Research, February 2006
|
| DOI | 10.1158/1078-0432.ccr-05-2013 |
| Pubmed ID | |
| Authors |
Scott J. Antonia, Noweeda Mirza, Ingo Fricke, Alberto Chiappori, Patricia Thompson, Nicholas Williams, Gerold Bepler, George Simon, William Janssen, Ji-Hyun Lee, Kerstin Menander, Sunil Chada, Dmitry I. Gabrilovich |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Japan | 1 | 25% |
| Spain | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 50% |
| Scientists | 1 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| South Africa | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 131 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 21 | 16% |
| Student > Ph. D. Student | 17 | 13% |
| Student > Bachelor | 16 | 12% |
| Student > Master | 11 | 8% |
| Professor | 10 | 7% |
| Other | 26 | 19% |
| Unknown | 34 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 30 | 22% |
| Medicine and Dentistry | 27 | 20% |
| Biochemistry, Genetics and Molecular Biology | 16 | 12% |
| Immunology and Microbiology | 10 | 7% |
| Engineering | 4 | 3% |
| Other | 10 | 7% |
| Unknown | 38 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 233. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 December 2023.
All research outputs
#151,475
of 24,257,963 outputs
Outputs from Clinical Cancer Research
#61
of 12,967 outputs
Outputs of similar age
#293
of 160,785 outputs
Outputs of similar age from Clinical Cancer Research
#2
of 163 outputs
Altmetric has tracked 24,257,963 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,967 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 160,785 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 163 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.